Jen Fuson

In an article for Forbes.com, Phillips & Cohen partner Erika Kelton argues for clarity in the SEC’s position as it considers changes to its whistleblower program: The future success of the Securities...

Kickbacks by the pharmaceutical industry come in many forms. One of the latest twists in pharma kickbacks involves patient assistance foundations conspiring with drug manufacturers to increase manufacturers’...

The US Securities and Exchange Commission is reconsidering whether to adopt proposed new rules for the SEC whistleblower program that could have a significant impact on the program by limiting whistleblower...

Phillips & Cohen partner Sean McKessy is quoted in CQ Roll Call about how proposed changes to the SEC’s whistleblower program could have a chilling effect on fraud reporting. “Having been...

In The Wall Street Journal, Phillips & Cohen partner Erika Kelton explains how proposed limits to the SEC’s whistleblower rewards are hurting whistleblowers’ willingness to come forward:...

Phillips & Cohen partner Sean McKessy tells Reuters that the SEC risks pushing whistleblowers away if it makes changes to its whistleblower reward guidelines: Sean McKessy, who set up the SEC whistleblower...

In a Bloomberg Law article, Phillips & Cohen partner Erika Kelton explains some ramifications of an important ruling against SEC whistleblowers in the Deutsche Bank case. Deutsche Bank settled with...

The Wall Street Journal talked to Phillips & Cohen partner Erika Kelton about the CFTC’s outreach to whistleblowers in a story discussing the drop in CFTC whistleblower submissions and award rates...

Phillips & Cohen partner Erika Kelton reacts to an agreement made between the US Department of Justice and the US Department of Housing and Urban Development to eschew the False Claims Act as the primary...

Phillips & Cohen partner Erika Kelton underscores the significance of allegations against e-cigarette manufacturer Juul, raised in a recently-filed lawsuit by Juul’s former senior vice president...